6-Dimethylaminopurine
6-Dimethylaminopurine Basic information
- Product Name:
- 6-Dimethylaminopurine
- Synonyms:
-
- TIMTEC-BB SBB008765
- N,N-DIMETHYL-N-(4-PYRIDINYL)AMINE
- N,N'-DIMETHYL-4-PYRIDINAMINE
- N6,N6-DIMETHYLADENINE
- N4,N4-DIMETHYLPYRIDIN-4-AMINE
- N-(4-PYRIDYL)DIMETHYLAMINE
- 6-Dimethyladenine
- 6-Dimethylamino-9H-purine
- CAS:
- 938-55-6
- MF:
- C7H9N5
- MW:
- 163.18
- EINECS:
- 213-344-3
- Product Categories:
-
- Nitrogen cyclic compounds
- Purine
- Nucleotides and Nucleosides
- Bases & Related Reagents
- Nucleotides
- Mol File:
- 938-55-6.mol
6-Dimethylaminopurine Chemical Properties
- Melting point:
- 259-262 °C(lit.)
- Boiling point:
- 162 °C (50 mmHg)
- Density
- 1.1407 (rough estimate)
- refractive index
- 1.6380 (estimate)
- Flash point:
- 110 °C
- storage temp.
- -20°C
- solubility
- methanol: 0.1 g/mL, clear
- form
- prilled
- pka
- 9.38±0.20(Predicted)
- color
- off-white to yellow
- BRN
- 7634
- InChIKey
- BVIAOQMSVZHOJM-UHFFFAOYSA-N
- CAS DataBase Reference
- 938-55-6(CAS DataBase Reference)
- NIST Chemistry Reference
- 1H-Purin-6-amine, N,N-dimethyl-(938-55-6)
MSDS
- Language:English Provider:N,N-Dimethyl-9H-purin-6-amine
- Language:English Provider:SigmaAldrich
- Language:English Provider:ACROS
- Language:English Provider:ALFA
6-Dimethylaminopurine Usage And Synthesis
Chemical Properties
white to light yellow crystal powder
Uses
6-Dimethylaminopurine is a serine threonine protein kinase inhibitor. It inhibits the germinal vesicle breakdown and the meiotic maturation of oocytes. It can be used to rtificially lengthen the pre-maturation period of oocyte growth, in vitro, by inhibiting germinal vesicle breakdown in mouse and human oocytes.
Definition
ChEBI: 6-Dimethylaminopurine is a tertiary amine that is adenine substituted at N-6 by geminal methyl groups. It is functionally related to an adenine.
Application
6-(Dimethylamino)purine has been used:
as a supplement in GR-1 aa medium (bovine medium) for parthenogenetic activation of bovine oocytes to study its potential for embryo development.
in the activation step during the production of nuclear transfer embryos.
as a supplement in HCR2aa medium to activate interspecies embryos derived from interspecies somatic cell nuclear transfer (iSCNT) technique.
A purine antagonist.
In the benzodiazepine receptor (BZR) binding assay, it inhibits the binding of 1.5 nM [3H]diazepam at 100uM in rat brains.
Preparation
6-Dimethylaminopurine synthesis: 2-Methylmercapto-4-amino-6-dimethylaminopyrimidine (VI) was smoothly nitrosated in 10% acetic acid to the 5-nitrosopyrimidine (V) in 95% yield. Reduction of V with sodium hydrosulfite to the triamine (IV), followed by formylation gave the 5-formamidopyrimidine (VII) in 76% over-all yield for the two steps. Reductive formylation of V directly to VI1 with zinc and formic acid, although more rapid, was less efficient (50% yield). Ring closure of VII to 2-methyhercapto-6-dimethylaminopurine (X) was best done on a small scale by short fusion at 250°(99% yield), although boiling quinoline, formamide, or dilute alcoholic sodium hydroxide could also be employed. The latter reagent was most efficient on a large scale. Desulfurization of X with Raney nickel (7) in 1 N sodium hydroxide at 100° afforded the final product, 6-dimethylaminopurine (XII) in 43% yield.This compound was identical in all respects with the C7H9N5 moiety from puromycin (2).
General Description
6-(Dimethylamino)purine (6-DMAP) is a purine-based metabolite with two condensed heterocyclic rings and two methyl groups linked to the amino group of the purine unit of adenine.
Biochem/physiol Actions
6-(Dimethylamino)purine (6-DMAP) is a protein kinase and cyclin-dependent kinase inhibitor. It acts as a secondary metabolite and mediates RNA modification. 6-DMAP is a potent cytokinetic inhibitor and is used in parthenogenesis and meiosis studies. It is also used to promote pronuclei formation in mammalian oocytes. 6-DMAP is a dual fluorescence molecule according to femtosecond fluorescence up-conversion spectroscopy studies.
Purification Methods
It is purified by recrystallisation from H2O, EtOH (0.32g in 10mL) or CHCl3. [Albert & Brown J Chem Soc 2060 1954, UV: Mason J Chem Soc 2071 1954.] The monohydrochloride crystallises from EtOH/Et2O, m 2 5 3o(dec) [Elion et al. J Am Chem Soc 74 411 1952], the dihydrochloride has m 225o(dec) and the picrate has m 245o (235-236.5o) [Fryth et al. J Am Chem Soc 80 2736 1958]. [Beilstein 26 III/IV 3566.]
6-Dimethylaminopurine Preparation Products And Raw materials
Raw materials
6-DimethylaminopurineSupplier
- Tel
- 0577-64498589 15325081899
- sales@win-winchemical.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 021-61259108 18621169109
- market03@meryer.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 021-67121386
- Sales-CN@TCIchemicals.com
6-Dimethylaminopurine(938-55-6)Related Product Information
- Dimethyl sulfoxide
- DIMETHYLAMINOPYRIDINE, POLYMER-BOUND
- Dimethyl phthalate
- ETHANE
- 2,6-Diaminopurine
- 2,6-Lutidine
- Dimethyl ether
- N,N-Dimethylformamide
- N,N-Dimethyl-1,4-phenylenediamine
- Dimethyl fumarate
- Dimethyl sulfide
- PUROMYCIN AMINONUCLEOSIDE
- PUROMYCIN DIHYDROCHLORIDE
- PUROMYCIN DIHYDROCHLORIDE
- 6-DIMETHYLAMINOPURINE-9-RIBOSIDE,6-Dimethylaminopurine D-riboside,6-dimethylaminopurine 9-riboside*crystalline
- 4-Dimethylaminopyridine
- Purine
- PUROMYCIN